Discontinued — last reported Q3 '20
Life Sciences — Goodwill
Becton, Dickinson and Company Life Sciences — Goodwill increased by 3905.4% to $25.96B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.8%, from $26.44B to $25.96B. Over 5 years (FY 2020 to FY 2025), Life Sciences — Goodwill shows relatively stable performance with a 1.9% CAGR.
Analysis
How to read this metric
A stable or growing balance indicates successful integration of past acquisitions, while a sudden decrease suggests potential impairment of acquired assets.
Detailed definition
This metric represents the excess purchase price paid for acquisitions within the Life Sciences segment over the fair va...
Peer comparison
High goodwill balances are common in consolidated industries where companies frequently acquire smaller diagnostic or research technology firms.
bdx_segment_life_sciences_goodwillHistorical Data
| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.81B | $839.00M | $23.89B | $836.00M | $24.12B | $880.00M | $24.10B | $902.00M | $23.97B | $895.00M | $24.62B | $888.00M | $24.76B | $898.00M | $24.78B | $899.00M | $24.58B | $901.00M | $24.52B | $897.00M | $24.60B | $901.00M | $24.57B | $900.00M | $24.55B | $899.00M | $26.47B | $904.00M | $26.33B | $896.00M | $26.44B | $899.00M | $26.60B | $913.00M | $25.96B | $648.00M | $26.62B | $648.00M | $25.96B |
| QoQ Change | — | -96.5% | >999% | -96.5% | >999% | -96.4% | >999% | -96.3% | >999% | -96.3% | >999% | -96.4% | >999% | -96.4% | >999% | -96.4% | >999% | -96.3% | >999% | -96.3% | >999% | -96.3% | >999% | -96.3% | >999% | -96.3% | >999% | -96.6% | >999% | -96.6% | >999% | -96.6% | >999% | -96.6% | >999% | -97.5% | >999% | -97.6% | >999% |
| YoY Change | — | — | — | — | — | — | — | — | +0.6% | -96.2% | +3.1% | -96.3% | +2.7% | -96.3% | +2.8% | -96.3% | +2.6% | -96.2% | -0.4% | -96.4% | -0.7% | -96.4% | -0.9% | -96.4% | -0.2% | -96.3% | +7.9% | -96.3% | +7.0% | -96.4% | +7.6% | -96.3% | +8.4% | -96.3% | -1.9% | -97.6% | +1.1% | -97.5% | -1.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's life sciences — goodwill?
- Becton, Dickinson and Company (BDX) reported life sciences — goodwill of $25.96B in Q1 2026.
- How has Becton, Dickinson and Company's life sciences — goodwill changed year-over-year?
- Becton, Dickinson and Company's life sciences — goodwill decreased by 1.8% year-over-year, from $26.44B to $25.96B.
- What is the long-term trend for Becton, Dickinson and Company's life sciences — goodwill?
- Over 5 years (2020 to 2025), Becton, Dickinson and Company's life sciences — goodwill has grown at a 1.9% compound annual growth rate (CAGR), from $23.60B to $25.96B.
- What does life sciences — goodwill mean?
- The value of intangible assets like brand and customer base recorded after acquiring businesses for the Life Sciences segment.